Evidence map›Paper›PMID 26628093›Full record

ArticleDevelopment (Cambridge, England)2015

Brg1 coordinates multiple processes during retinogenesis and is a tumor suppressor in retinoblastoma.

Issam Aldiri, Itsuki Ajioka, Beisi Xu, Jiakun Zhang, Xiang Chen, Claudia Benavente, David Finkelstein, Dianna Johnson, Jennifer Akiyama, Len A Pennacchio and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Development (Cambridge, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Epigenetic Switches in Retinal Homeostasis and Target for Drug Development.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Review
  7. Review
  8. Epigenetic regulation of retinal development.Epigenetics & chromatin · 2021
    Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Samd7 is a cell type-specific PRC1 component essential for establishing retinal rod photoreceptor identity.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  15. Article
  16. Article
  17. BANCR: a cancer-related long non-coding RNA.American journal of cancer research · 2017
    Review
  18. Differential Expression ofFrontiers in molecular neuroscience · 2017
    Article
  19. Epigenetic regulation of human retinoblastoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Issam AldiriDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Itsuki AjiokaCenter for Brain Integration Research (CBIR), Tokyo Medical and Dental University (TMDU), Tokyo 113-8510, Japan.
Beisi XuDepartment of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Jiakun ZhangDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Xiang ChenDepartment of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Claudia BenaventeDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
David FinkelsteinDepartment of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Dianna JohnsonDepartment of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Jennifer AkiyamaLawrence Berkeley National Laboratory, Genomics Division, Berkeley, CA 94701, USA Department of Energy, Joint Genome Institute, Walnut Creek, CA 94598, USA.
Len A PennacchioLawrence Berkeley National Laboratory, Genomics Division, Berkeley, CA 94701, USA Department of Energy, Joint Genome Institute, Walnut Creek, CA 94598, USA.
Michael A DyerDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN 38163, USA Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA michael.dyer@stjude.org.
St. Jude Children's Research Hospital · USHoward Hughes Medical Institute · USJoint Genome Institute · USLawrence Berkeley National Laboratory · USTokyo Medical and Dental University · JPUniversity of Tennessee Health Science Center · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
Generation of an In Vivo Human Genome Transcriptional Enhancer DatasetR01HG003988 · NHGRI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI Len Alexander Pennacchio · 2006 to 2026
$24.1M
Center for Mammalian Regulatory GenomicsU54HG006997 · NHGRI · LUDWIG INSTITUTE FOR CANCER RES LTD · PI REN, BING · 2012 to 2016
$14.3M
Proliferation Control in the Retina: The Rb FamilyR01EY014867 · NEI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI DYER, MICHAEL A · 2003 to 2012
$4.5M
Proliferation and Differentiation of Retinal Stem CellsR01EY018599 · NEI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI DYER, MICHAEL A · 2008 to 2011
$2.5M
Research Project: Genome-Wide Atlas of Craniofacial Transcriptional EnhancersU01DE020060 · NIDCR · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI VISEL, AXEL · 2009 to 2013
$2.1M
Molecular Targeted Therapy for RetinoblastomaR01CA168875 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI DYER, MICHAEL A · 2012 to 2016
$1.8M
Howard Hughes Medical InstituteNCI NIH HHS CA168875NCI NIH HHS CA21765NCI NIH HHS P30 CA021765NCI NIH HHS R01 CA168875NEI NIH HHS EY014867NEI NIH HHS EY018599NEI NIH HHS R01 EY014867NEI NIH HHS R01 EY018599NHGRI NIH HHS R01 HG003988NHGRI NIH HHS R01HG003988NHGRI NIH HHS U54 HG006997NHGRI NIH HHS U54HG006997NIDCR NIH HHS U01 DE020060NIDCR NIH HHS U01DE020060NIH
6 · The paper itself

Abstract

Retinal development requires precise temporal and spatial coordination of cell cycle exit, cell fate specification, cell migration and differentiation. When this process is disrupted, retinoblastoma, a developmental tumor of the retina, can form. Epigenetic modulators are central to precisely coordinating developmental events, and many epigenetic processes have been implicated in cancer. Studying epigenetic mechanisms in development is challenging because they often regulate multiple cellular processes; therefore, elucidating the primary molecular mechanisms involved can be difficult. Here we explore the role of Brg1 (Smarca4) in retinal development and retinoblastoma in mice using molecular and cellular approaches. Brg1 was found to regulate retinal size by controlling cell cycle length, cell cycle exit and cell survival during development. Brg1 was not required for cell fate specification but was required for photoreceptor differentiation and cell adhesion/polarity programs that contribute to proper retinal lamination during development. The combination of defective cell differentiation and lamination led to retinal degeneration in Brg1-deficient retinae. Despite the hypocellularity, premature cell cycle exit, increased cell death and extended cell cycle length, retinal progenitor cells persisted in Brg1-deficient retinae, making them more susceptible to retinoblastoma. ChIP-Seq analysis suggests that Brg1 might regulate gene expression through multiple mechanisms.

Indexed as

AnimalsApoptosisBody PatterningCell AdhesionCell CycleCell DifferentiationCell LineageCell MovementCell ProliferationDisease Models, AnimalDNA HelicasesEpigenesis, GeneticGene Expression ProfilingGene Expression Regulation, DevelopmentalGene Expression Regulation, NeoplasticGenes, Tumor SuppressorDNA HelicasesNuclear ProteinsSmarca4 protein, mouseTranscription FactorsEpigeneticsMouseRetina developmentRetinoblastomaSWI/SNF

Identifiers

PMID26628093
PMCPMC4712833
OpenAlexW2182160540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.